Log In
Print
BCIQ
Print
Print this Print this
 

Seglin OGA inhibitor

  Manage Alerts
Collapse Summary General Information
Company Summit Corp. plc
DescriptionO-linked N-acetylglucosaminidase (O-GlcNAcase) inhibitor
Molecular Target O-linked N-acetylglucosaminidase (O-GlcNAcase)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today